PHARMA Stock Overview
An investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Pharmaniaga Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.36 |
| 52 Week High | RM 0.47 |
| 52 Week Low | RM 0.29 |
| Beta | 1.41 |
| 11 Month Change | -6.49% |
| 3 Month Change | -6.49% |
| 1 Year Change | -11.11% |
| 33 Year Change | -56.36% |
| 5 Year Change | -14.69% |
| Change since IPO | 211.15% |
Recent News & Updates
Recent updates
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 18
Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S
May 09Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 19Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price
Oct 03Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?
Jul 19Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?
Feb 18Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital
Dec 10Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts
Nov 24We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings
Aug 27Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet
May 28Shareholder Returns
| PHARMA | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | -4.0% | 1.3% | -0.2% |
| 1Y | -11.1% | 25.7% | 9.7% |
Return vs Industry: PHARMA underperformed the MY Healthcare industry which returned 25.7% over the past year.
Return vs Market: PHARMA underperformed the MY Market which returned 9.7% over the past year.
Price Volatility
| PHARMA volatility | |
|---|---|
| PHARMA Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in MY Market | 10.1% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: PHARMA has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: PHARMA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,476 | Zulkifli Bin Jafar | www.pharmaniaga.com |
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products.
Pharmaniaga Berhad Fundamentals Summary
| PHARMA fundamental statistics | |
|---|---|
| Market cap | RM 518.84m |
| Earnings (TTM) | -RM 56.32m |
| Revenue (TTM) | RM 3.48b |
0.1x
P/S Ratio-9.2x
P/E RatioIs PHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMA income statement (TTM) | |
|---|---|
| Revenue | RM 3.48b |
| Cost of Revenue | RM 3.15b |
| Gross Profit | RM 323.56m |
| Other Expenses | RM 379.88m |
| Earnings | -RM 56.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 9.30% |
| Net Profit Margin | -1.62% |
| Debt/Equity Ratio | -487.5% |
How did PHARMA perform over the long term?
See historical performance and comparison